409 related articles for article (PubMed ID: 28776396)
1. Paclitaxel-loaded nanoparticles decorated with bivalent fragment HAb18 F(ab')
Jin C; Bai L; Lin L; Wang S; Yin X
Artif Cells Nanomed Biotechnol; 2018 Aug; 46(5):1076-1084. PubMed ID: 28776396
[TBL] [Abstract][Full Text] [Related]
2. Improved therapeutic effect of DOX-PLGA-PEG micelles decorated with bivalent fragment HAb18 F(ab')(2) for hepatocellular carcinoma.
Jin C; Qian N; Zhao W; Yang W; Bai L; Wu H; Wang M; Song W; Dou K
Biomacromolecules; 2010 Sep; 11(9):2422-31. PubMed ID: 20831277
[TBL] [Abstract][Full Text] [Related]
3. Cell-penetrating Peptide-modified Targeted Drug-loaded Phase-transformation Lipid Nanoparticles Combined with Low-intensity Focused Ultrasound for Precision Theranostics against Hepatocellular Carcinoma.
Zhao H; Wu M; Zhu L; Tian Y; Wu M; Li Y; Deng L; Jiang W; Shen W; Wang Z; Mei Z; Li P; Ran H; Zhou Z; Ren J
Theranostics; 2018; 8(7):1892-1910. PubMed ID: 29556363
[No Abstract] [Full Text] [Related]
4. Preparation and activity of conjugate of monoclonal antibody HAb18 against hepatoma F(ab')(2) fragment and staphylococcal enterotoxin A.
Yang LJ; Sui YF; Chen ZN
World J Gastroenterol; 2001 Apr; 7(2):216-21. PubMed ID: 11819763
[TBL] [Abstract][Full Text] [Related]
5. [Preparation and in vitro killing effect of adriamycin-loaded immunonanosphere against hepatoma led by F (ab')2 Fragment of monoclonal antibodies].
Li Y; Cai M; Wang Z; Liu X; Liang Z
Hua Xi Yi Ke Da Xue Xue Bao; 2002 Jan; 33(1):8-11, 14. PubMed ID: 12599415
[TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of targeted DOX-PLGA-PEG micelles decorated with bivalent fragment HAb18 F(ab')2 for treatment of hepatocellular carcinoma.
Jin C; Yang W; Bai L; Wang J; Dou K
J Control Release; 2011 Nov; 152 Suppl 1():e14-5. PubMed ID: 22195807
[No Abstract] [Full Text] [Related]
7. Curcumin-loaded galactosylated BSA nanoparticles as targeted drug delivery carriers inhibit hepatocellular carcinoma cell proliferation and migration.
Huang Y; Hu L; Huang S; Xu W; Wan J; Wang D; Zheng G; Xia Z
Int J Nanomedicine; 2018; 13():8309-8323. PubMed ID: 30584302
[TBL] [Abstract][Full Text] [Related]
8. Synergism of cisplatin-oleanolic acid co-loaded calcium carbonate nanoparticles on hepatocellular carcinoma cells for enhanced apoptosis and reduced hepatotoxicity.
Khan MW; Zhao P; Khan A; Raza F; Raza SM; Sarfraz M; Chen Y; Li M; Yang T; Ma X; Xiang G
Int J Nanomedicine; 2019; 14():3753-3771. PubMed ID: 31239661
[No Abstract] [Full Text] [Related]
9. Folate-decorated hybrid polymeric nanoparticles for chemically and physically combined paclitaxel loading and targeted delivery.
Wang J; Liu W; Tu Q; Wang J; Song N; Zhang Y; Nie N; Wang J
Biomacromolecules; 2011 Jan; 12(1):228-34. PubMed ID: 21158381
[TBL] [Abstract][Full Text] [Related]
10. Low density lipoprotein mimic nanoparticles composed of amphipathic hybrid peptides and lipids for tumor-targeted delivery of paclitaxel.
Qian J; Xu N; Zhou X; Shi K; Du Q; Yin X; Zhao Z
Int J Nanomedicine; 2019; 14():7431-7446. PubMed ID: 31686815
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular Carcinoma Targeting and Pharmacodynamics of Paclitaxel Nanoliposomes Modified by Glycyrrhetinic Acid and Ferric Tetroxide.
Zhao L; Liang L; Guo M; Li M; Yu X; Wang Y; Wang Y
Curr Top Med Chem; 2021 Oct; 21(14):1268-1284. PubMed ID: 34620053
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of cell penetrating peptide coated Mn:ZnS nanoparticles for paclitaxel delivery to cancer cells.
Rejinold NS; Han Y; Yoo J; Seok HY; Park JH; Kim YC
Sci Rep; 2018 Jan; 8(1):1899. PubMed ID: 29382898
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of radioimmunotherapeutic agent of direct labeling mAb 188Re-HAb18.
Lou C; Chen ZN; Bian HJ; Li J; Zhou SB
World J Gastroenterol; 2002 Feb; 8(1):69-73. PubMed ID: 11833074
[TBL] [Abstract][Full Text] [Related]
14. pH-responsive delivery vehicle based on RGD-modified polydopamine-paclitaxel-loaded poly (3-hydroxybutyrate-co-3-hydroxyvalerate) nanoparticles for targeted therapy in hepatocellular carcinoma.
Wu M; Zhong C; Zhang Q; Wang L; Wang L; Liu Y; Zhang X; Zhao X
J Nanobiotechnology; 2021 Feb; 19(1):39. PubMed ID: 33549107
[TBL] [Abstract][Full Text] [Related]
15. Hydrotropic polymeric mixed micelles based on functional hyperbranched polyglycerol copolymers as hepatoma-targeting drug delivery system.
Zhang X; Zhang X; Yu P; Han Y; Li Y; Li C
J Pharm Sci; 2013 Jan; 102(1):145-53. PubMed ID: 23132353
[TBL] [Abstract][Full Text] [Related]
16. N-acetylgalactosamine-decorated nanoliposomes for targeted delivery of paclitaxel to hepatocellular carcinoma.
Li T; Yu P; Chen Y; Sun B; Dong P; Zhu T; Meng X
Eur J Med Chem; 2021 Oct; 222():113605. PubMed ID: 34126457
[TBL] [Abstract][Full Text] [Related]
17. Honokiol nanoparticles based on epigallocatechin gallate functionalized chitin to enhance therapeutic effects against liver cancer.
Tang P; Sun Q; Yang H; Tang B; Pu H; Li H
Int J Pharm; 2018 Jul; 545(1-2):74-83. PubMed ID: 29715531
[TBL] [Abstract][Full Text] [Related]
18. Novel free-paclitaxel-loaded redox-responsive nanoparticles based on a disulfide-linked poly(ethylene glycol)-drug conjugate for intracellular drug delivery: synthesis, characterization, and antitumor activity in vitro and in vivo.
Chuan X; Song Q; Lin J; Chen X; Zhang H; Dai W; He B; Wang X; Zhang Q
Mol Pharm; 2014 Oct; 11(10):3656-70. PubMed ID: 25208098
[TBL] [Abstract][Full Text] [Related]
19. In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells.
Gao C; Pan J; Lu W; Zhang M; Zhou L; Tian J
Anticancer Drugs; 2009 Oct; 20(9):807-14. PubMed ID: 19696655
[TBL] [Abstract][Full Text] [Related]
20. Glycyrrhizin-modified O-carboxymethyl chitosan nanoparticles as drug vehicles targeting hepatocellular carcinoma.
Shi L; Tang C; Yin C
Biomaterials; 2012 Oct; 33(30):7594-604. PubMed ID: 22796165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
